1. Home
  2. NRIX vs NTB Comparison

NRIX vs NTB Comparison

Compare NRIX & NTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$14.76

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo Bank of N.T. Butterfield & Son Limited (The) Voting

NTB

Bank of N.T. Butterfield & Son Limited (The) Voting

SELL

Current Price

$56.08

Market Cap

2.3B

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
NRIX
NTB
Founded
2009
1858
Country
United States
Bermuda
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Commercial Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.3B
IPO Year
2020
2016

Fundamental Metrics

Financial Performance
Metric
NRIX
NTB
Price
$14.76
$56.08
Analyst Decision
Buy
Buy
Analyst Count
14
4
Target Price
$33.50
★ $66.00
AVG Volume (30 Days)
★ 3.4M
156.1K
Earning Date
10-12-2026
10-27-2026
Dividend Yield
N/A
★ 3.56%
EPS Growth
N/A
★ N/A
EPS
★ 3.26
N/A
Revenue
★ $76,987,000.00
N/A
Revenue This Year
$786.93
$5.42
Revenue Next Year
N/A
$86.83
P/E Ratio
★ $4.52
$9.64
Revenue Growth
★ 99.31
N/A
52 Week Low
$12.61
$44.63
52 Week High
$28.23
$64.17

Technical Indicators

Market Signals
Indicator
NRIX
NTB
Relative Strength Index (RSI) 25.08 43.26
Support Level $14.65 $54.66
Resistance Level $17.47 $56.84
Average True Range (ATR) 1.22 1.32
MACD -0.77 0.03
Stochastic Oscillator 0.23 30.17

Price Performance

Historical Comparison
NRIX
NTB

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

About NTB Bank of N.T. Butterfield & Son Limited (The) Voting

Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It offers banking services, comprising retail and corporate banking, and wealth management services, which consist of trust, private banking, and asset management business. The company operates through four reportable segments: Bermuda, Cayman, Channel Islands and the UK, and Other. In its Bermuda and Cayman segments, the company offers retail banking and wealth management services. In the Channel Islands and the UK segment, the company offers retail and corporate banking and wealth management services, and the Other segment includes its operations in the Bahamas, Canada, Mauritius, Singapore, and Switzerland. Maximum revenue for the company is generated from its business in Bermuda.

Share on Social Networks: